What is Atalo?
Atalo CBD operates as a comprehensive agriculture and biotechnology enterprise focused on the production of full-spectrum CBD products derived from hemp. Leveraging over seven generations of hemp farming expertise, the company is dedicated to developing certified industrial hemp seed and pioneering innovative agronomic practices within Kentucky. Atalo's operations extend to state-of-the-art extraction and processing facilities, enabling the manufacture and sale of bulk CBD ingredients and white label products. The firm strategically positions itself to capitalize on the expanding hemp market by serving both consumers seeking premium CBD products and businesses requiring dependable hemp-derived ingredients.
How much funding has Atalo raised?
Atalo has raised a total of $657K across 1 funding round:
Private Equity
$657K
Private Equity (2016): $657K, investors not publicly disclosed
What's next for Atalo?
The substantial enterprise-level funding and recent strategic investment indicate Atalo is poised for significant scaling and market expansion. This capital infusion will likely fuel advancements in their agronomic research, enhance extraction and processing capabilities, and broaden their market reach for both bulk ingredients and white label offerings. Atalo's deep farming heritage combined with its biotechnology focus provides a strong foundation for continued innovation and leadership in the competitive CBD landscape. The company's strategic positioning suggests a focus on solidifying its supply chain and increasing its market share within the rapidly evolving hemp industry.
See full Atalo company page
